CRTC1 and renal carcinoma: Rapamycin, which predominantly inhibits TORC1 activity, abrogates invasion of normal as well as many cancer cells in vitro and metastasis of implanted tumor cells in mouse models, including pulmonary metastasis of human renal cancer cells [101], [102].